Sign in to view content

A Comparison of the Anatomical Efficacy of Brolucizumab Versus Aflibercept in nAMD Patients: Matched 16-Week Results From the HAWK and HARRIER Studies

Pravin U. Dugel, MD

Video
Published 2018

Related

LADDER Trial of the Port Delivery System with Ranibizumab: Initial Study Results
Carl C. Awh, MD, FASRS
Annual Meeting Talks
2018
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Should Baseline Characteristics Affect Choice of Treatment?
Susan B. Bressler, MD, FASRS
Annual Meeting Talks
2018
Heads-Free!: 3D Head-Mounted Display System for Vitreoretinal Surgery
Murat Oncel, MD, FASRS
Annual Meeting Talks
2018

Category: Age-Related Macular Degeneration

See more